Functional Adaptive Hyperfiltration May Affect Renal Function after Radical Nephrectomy

Share this content:
Adaptive hyperfiltration may be more important than structural adaptive hypertrophy for the recovery of renal function following radical nephrectomy.
Adaptive hyperfiltration may be more important than structural adaptive hypertrophy for the recovery of renal function following radical nephrectomy.

New data are suggesting functional adaptive hyperfiltration may be more important than structural adaptive hypertrophy for the recovery of renal function following radical nephrectomy (RN).

Researchers at the Samsung Medical Center, Sungkyunkwan University School of Medicine in Korea have found that patients with renal cell carcinoma (RCC) who have lower preoperative GFR had less of a reduction in postoperative renal function than patients with higher preoperative GFR due to greater degrees of functional hyperfiltration.1

Choi and colleagues investigated structural hypertrophy and functional hyperfiltration as compensatory adaptations following RN in 543 patients with RCC.

All the patients were retrospectively identified and underwent RN between 1997 and 2012. Patients were classified according to preoperative GFR and CKD stage. The researchers assessed functional renal volume (FRV) through CT images taken within 2 months prior to surgery and 12 months after surgery.

The mean age of the patients was 56.0 years and the mean preoperative GFR was 83.2 mL/min/1.73m2. The mean preoperative FRV was 340.6 cm3 and the mean preoperative GFR/FRV was 0.25 ml/min/1.73m2/cm3.

The researchers found the reduction in GFR was statistically significant according to CKD stage (no CKD -31.2% compared to CKD stage 2 -26.5%). The reduction in GFR for CKD stage 3 was -12.8%.

RELATED: AUA 2015: New Studies May Enhance Ability to Predict Renal Cell Carcinoma Outcomes

While the degree of hypertrophic FRV in the remnant kidney was not statistically significant, the change in GFR/FRV was statistically significant (no CKD was 18.5% compared to 20.1% for CKD stage 2).

The change in GFR/FRV was 45.9% in the CKD stage 3. The researchers write that factors that increased GFR/FRV above the mean value were body mass index, diabetes mellitus, hypertension, and CKD stage.

Page 1 of 2

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters